Skip to content
Governance Register

← US public companies

Therapeutics Acquisition Corp.

SEC CIK 1811764 · TXAC · last insider filing 2023-12-27

Directors (from insider filings)

NameCapacity as filedFilings
Silber Allan C Director · Executive Chairman filed 2021 - 2023
Lubner David Charles Director filed 2020 - 2023
Malik Rajesh Director filed 2021 - 2023
Fleshner Neil E. Director · Chief Medical Officer filed 2021 - 2023
Goodman Jonathan R. Director filed 2021 - 2023
Margolin Yael Director filed 2021 - 2023
Mccann JOE A. Director · Chief Executive Officer filed 2021 - 2023
Hogue Gerald L. Director filed 2021 - 2023
Martell Bridget A Director filed 2023 - 2023
Gilmour Margaret E. Director filed 2021 - 2021
RA Capital Healthcare Fund LP Director filed 2021 - 2021
RA Capital Management, LLC Director filed 2021 - 2021
Kolchinsky Peter Director · Chief Executive Officer filed 2020 - 2021
Shah Rajeev M. Director filed 2021 - 2021
Gray Michael Director filed 2020 - 2020
Grau Daniel Director filed 2020 - 2020
Hammond Matthew Director · Chief Financial Officer filed 2020 - 2020

Officers (from insider filings)

NameTitle as filedFilings
Demers William L. Chief Financial Officer filed 2021 - 2023
Jensen Jessica D. EVP Clinical Development filed 2021 - 2023
Kelly Justyna Chief Operating Officer filed 2021 - 2023
Gottlieb Michael M. Chief Commercial Officer filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.